Uveal Ganglioneuroma due to Germline
Ganglioneuroma of the choroid is a rare tumor usually associated with neurofibromatosis type 1 (NF1), with only 9 cases previously reported [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Cowden syndrome is caused by a germline mutation in the PTEN tumor suppressor gene and is characterized by hamartomatous growths as well as an increased risk for breast, thyroid, endometrial, renal, and gastrointestinal cancer [11] . To our knowledge, no association between uveal ganglioneuroma and Cowden syndrome has been previously reported. Here, we describe an informative case of a uveal ganglioneuroma presenting as a unilateral infantile glaucoma leading to a diagnosis of Cowden syndrome via targeted next-generation sequencing.
Methods
Retrospective analysis of clinical, histopathologic, and genetic records of 1 patient was performed. Targeted next-generation sequencing of 510 cancer-associated genes was performed on genomic DNA isolated from peripheral blood and microdissected tumor tissue in the Clinical Cancer Genomics Laboratory at the University of California, San Francisco. A standard bioinformatics pipeline was used to assess for germline and somatic single-nucleotide variants, small insertions/deletions, structural variants, and copy number changes.
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A 2-year-old girl born at 31 weeks with a history of macrocephaly, developmental delay, and gradual enlargement of the right eye presented with elevated intraocular pressure in the right eye. On initial examination under anesthesia, the intraocular pressure was 28 mm Hg in the right eye and 19 mm Hg in the left eye. The axial length was 26.0 mm in the right eye compared to 20.6 mm in the left eye. Examination of the anterior segment revealed a curvilinear opacity in the inferior cornea, peripheral anterior synechiae with poor pupillary dilation, and ectropion uveae in the right eye ( Fig. 1 a) . Fundus examination revealed a dysplastic-appearing right optic nerve with a cup-to-disc ratio of 0.8 and rim thinning superiorly. Examination of the left eye was unremarkable. The patient's intraocular pressure remained uncontrolled despite maximal medical management, and an Ahmed valve was subsequently placed in the right eye 6 months after the initial presentation. The intraocular pressure in the right eye remained uncontrolled despite this, and multiple subsequent surgeries were performed over the following 2 years due to progressive iris thickening and pupillary membrane formation. B scan ( Fig. 1 b) and MRI ( Fig. 1 c) of the right eye showed a shallow serous retinal detachment and diffuse choroidal thickening. A small biopsy of the iris at the time of a pupilloplasty procedure revealed a spindle cell neoplasm with tumor cells that showed immunostaining for S-100, SOX-10, and GFAP ( Fig. 2a -d) but not for HMB-45 and Melan-A (not shown). There were no morphologic features to suggest malignancy, with MIB-1 labeling present in approximately 2% of the tumor cells ( Fig. 2 e) .
The clinical presentation with a diffusely thickened uveal track, in conjunction with this small iris biopsy, suggested the possibility of neurofibroma. As such, the patient was subsequently referred for NF1 evaluation. The patient had 1 café-au-lait macula on the right buttock, but no other skin lesions or other stigmata of NF1. Her family history was negative for neurofibromatosis. Peripheral blood testing for NF1 was negative for pathogenic mutations, and chromosomal microarray analysis was unremarkable.
An additional pupilloplasty procedure was performed 6 months later, and an additional iris biopsy at that time showed the same spindle-shaped cells with small ovoid nuclei without prominent nucleoli or significant pleomorphism. The eosinophilic cytoplasm was slightly wavy. These cells did not show staining with HMB-45 or smooth muscle actin (SMA) antibodies. They did stain positively for neurofilament and S-100 and were felt to be most consistent with a neurofibroma ( Fig. 3 ) . At 5 years of age, the patient developed a blind, painful eye due to uncontrolled intraocular pressure, and the eye was enucleated ( Fig. 4 ) . On histopathology, the entire uveal tract including the iris, ciliary body, and choroid was infiltrated by neoplastic spindle cells with admixed large dysmorphic ganglion cells diagnostic of ganglioneuroma ( Fig. 5 ) . The neoplastic ganglion cells demonstrated immunopositivity for synaptophysin and neuronspecific enolase, while the Schwannian spindle cells showed immunopositivity for S-100 and SOX-10. MIB-1 showed a low proliferation index ( Fig. 6 ). Antibodies against Melan-A, HMB-45, and SMA failed to stain the tumor cells. The long and short posterior ciliary nerves were enlarged, and the retina was detached by an eosinophilic exudate posteriorly. There were focal areas of fullthickness retinal atrophy. The sclera was thinned posteriorly, and the optic nerve was slightly atrophic.
Targeted next-generation sequencing of 510 cancerassociated genes was performed on genomic DNA isolated from the patient's peripheral blood and microdissected tumor tissue. This testing revealed a germline nonsense mutation in the PTEN gene (p.L146 * ) with copy number neutral loss of heterozygosity in the tumor. Additional somatic genomic alterations such as NF1 or RET mutations were not identified. A diagnosis of Cowden syndrome was established.
The patient was evaluated by the pediatric genetics service and is to undergo annual screening including yearly thyroid ultrasound and dermatologic examination, as well as neurologic, psychologic, and school evaluations. A strong family history of early-onset uterine cancer was elicited in her maternal grandmother and multiple of her maternal grandmother's siblings. Genetic testing was also recommended for the patient's 2 siblings aged 4 and 7, which is currently underway. Additionally, the patient was found to have an arteriovenous malformation in the left arm when she developed pain due to compartment syndrome, and she underwent surgical resection and fasciotomy.
Discussion
Ganglioneuroma is typically a benign, slow-growing tumor arising from neural crest cells that is most commonly found along the sympathetic chain in the posterior mediastinum, retroperitoneum, adrenal gland, and neck [12, 13] . Ganglioneuroma of the uveal tract is an extremely rare entity. These tumors can present with buphthalmos, intractable glaucoma, or as a blind, painful eye [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . On review of the literature, we found only 9 prior cases of uveal ganglioneuroma reported [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] , 7 of which were in the setting of newly diagnosed or previously established NF1 [1] [2] [3] [4] [5] [6] [7] [8] . One case of choroidal ganglioneuroma without confirmed NF1 has been reported in the German literature [9] , and 1 case was reported in the French literature of which details were not accessible [10] .
The PTEN hamartoma tumor syndrome includes a continuum of disorders including Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, and LhermitteDuclos disease, all caused by germline mutations in PTEN , a tumor suppressor gene [11] . The mutation is typically inherited in an autosomal dominant fashion, but in up to 44% of the cases, it occurs de novo with no prior family history [14] . Cowden syndrome is characterized by mucocutaneous findings including facial trichilemmomas, oral papillomas, mucocutaneous neuromas, and acral keratoses, but these are variable. Other features include vascular anomalies, lipomas, fibromas, benign thyroid nodules, gastrointestinal polyps, macrocephaly, and developmental delay [11, 15] . Gastrointestinal ganglioneuromatous polyps have as well been reported in patients with Cowden syndrome [16] . Importantly, these patients carry an increased risk for breast, thyroid, endometrial, renal, and gastrointestinal cancer [11, 15] . As such, enhanced cancer screening is recommended in these patients. For adults, the recommended regimen includes annual thyroid ultrasound and dermatologic examination beginning at the age of 18, mammography beginning at the age of 30, colonoscopy beginning at the age of 35, and renal imaging beginning at the age of 40 [17] . Tan et al. [15] described the prevalence of clinical features of PTEN mutations in the pediatric population and noted macrocephaly in 100%, autism or developmental delay in 82%, dermatologic features in 60%, vascular anomalies such as arteriovenous malformations or hemangiomas in 29%, and gastrointestinal polyps in 14% of the patients. Thyroid cancer and germ cell tumors were also noted to be associated. Thus, screening with annual thyroid ultrasound and dermatologic examinations as well as psychiatric and school evaluations are indicated in children.
To our knowledge, this is the first reported case of a uveal ganglioneuroma in a patient with PTEN hamartoma tumor syndrome. This diagnosis was only possible through tumor genetic profiling, which allowed us to identify a germline mutation that confers an increased lifelong risk for systemic malignancy to its carriers. Our patient exhibited a number of the clinical features of PTEN syndrome including developmental delay, macrocephaly, and arteriovenous malformation, but no unifying diagnosis had been established prior to genetic testing of her uveal tumor. This diagnosis has broad implications for future health, as patients are to undergo enhanced cancer screening per the above guidelines. It also carries great significance for a family, as siblings and other family members should undergo genetic testing, and an affected patient's future offspring have a 50% chance of inheriting the disease.
This case highlights how genomic profiling is revolutionizing cancer diagnostics. Combining histopathological evaluation and genetic evaluation should be considered in cases of diagnostic uncertainty. These tools may have particular use in rare tumors of the eye and elsewhere.
